Metagenomi, Inc. Common Stock (MGX NASDAQ) stock market data APIs
$2.147
0.07(3.3%)
as of November 7, 2025
Try our APIs with
free plan!
Metagenomi, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. Its genome editing toolbox includes nuclease-based genome editing, base editors, RNA-mediated integration, including prime editing, and DNA-mediated integration, such CRISPR-associated transposases. The company has a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop and commercialize investigational medicines using genome editing technologies; and a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited TCR-based therapeutic products exclusively in the field of treatment, prevention, or diagnosis of any human cancer. Metagenomi, Inc. was incorporated in 2016 and is headquartered in Emeryville, California.
Prev. Close
2.147
Open
2.2164
High
2.2164
Low
2.0138
52 wk Range
1.23-4.92
Market Cap
83 324 K
Shares Outstanding
37 533 K
Revenue
33 768 K
EPS
0
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Metagenomi, Inc. Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Metagenomi, Inc. Common Stock data using free add-ons & libraries
Get Metagenomi, Inc. Common Stock Fundamental Data
Metagenomi, Inc. Common Stock Fundamental data includes:
- Net Revenue: 33 768 K
- EBITDA: -86 295 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-12
- EPS/Forecast: -0.8
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Metagenomi, Inc. Common Stock News
New
Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Beat Estimates
Collegium Pharmaceutical (COLL) came out with quarterly earnings of $2.25 per share, beating the Zacks Consensus Estimate of $1.88 per share. This compares to earnings of $1.61 per share a year ago. T...
Metagenomi to use Amazon's chips for gene-editing tools
[Abstract luminous DNA molecule. Genetic and gene manipulation concept. Cut of replacing part of a DNA molecule. Medicine. Innovative in science. Medical science and biotechnology.] ipopba/iStock via ...
Promising Penny Stocks To Watch In October 2025
As the U.S. stock market navigates through a period of earnings reports and fluctuating commodity prices, investors continue to explore various avenues for potential growth. Penny stocks, often associ...
Metagenomi taps Amazon's custom chips to develop gene-editing tools
By Stephen Nellis SAN FRANCISCO (Reuters) -Biotech firm Metagenomi said it is using artificial intelligence chips from Amazon.com's cloud computing unit to power some of its work in developing gene-e...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
